Gyrodyne, LLC (GYRO) AI Stock Analysis
GYRO AI stock analysis summary
AI ResearchGyrodyne, LLC (GYRO) is a commercial real estate firm managing properties across the East Coast with an emphasis on medical office facilities. The company holds a market capitalization of $9.7M and generated trailing twelve month revenue of $2.7M. Over the past year, the stock fell 56.1%, while its operating margin over the trailing twelve months stood at -121.3%.
- Market cap
- $9.7M
- Revenue (TTM)
- $2.7M
- P/E
- 40.3x
- 1Y return
- -56.1% S&P 500 16.8%
- Avg. target
- —
Bull case
- The company maintained liquidity with a current ratio of 2.25 as of June 30, 2026.
- Insider ownership is substantial at 26.6%, indicating significant alignment between leadership and shareholders.
- Gross margin reached 71.5% in FY2015, up from 50.0% in FY2013.
Bear case
- Trailing twelve month operating margin stood at -121.3%, well below the peer median of 25.9%.
- The stock fell 56.1% over the past year and remains 36.4% below its 200-day moving average.
- Dilution occurred as the company's share count increased by 48.3% over the five years leading to FY2022.
What Gyrodyne does
Gyrodyne, LLC specializes in owning, leasing, and managing a diverse portfolio of commercial properties across the East Coast. Evolving from its roots in Long Island, the firm focuses on acquiring and enhancing specialized properties that serve medical professionals and related industries. Gyrodyne's portfolio is positioned to address tenant requirements for specialized office environments. The company emphasizes proactive tenant relations, sustainable property enhancements, and asset management practices to support long-term tenant relationships in the commercial real estate sector.
Growth and profitability
For the trailing twelve months ending December 31, 2023, Gyrodyne generated revenue of $2.7M with an operating margin of -121.3% and a profit margin of -137.1%. Diluted earnings per share over the trailing twelve months were $0.11, while quarterly revenue fell 1.8% year over year. In annual reporting, revenue was $5.0M in FY2013 with a net income of $46.1M, and $4.9M in FY2014 with net income of $147,553. In FY2015, reported revenue reached $5.60T with a net income of -$3.11T and a gross margin of 71.5%. Operating cash flow was -$8.1M in FY2013, -$5.5M in FY2014, and -$3,440 in FY2015.
Balance sheet and cash flow
As of June 30, 2026, Gyrodyne reported cash and short-term investments of $4.53T. Total assets were $57.9M against shareholders' equity of $27.1M. The company maintained a current ratio of 2.25. Over a five-year period through FY2022, the company's share count increased by 48.3%, while free cash flow stood at -$2.7M in FY2015.
Valuation and performance
Gyrodyne trades at a trailing price-to-earnings multiple of 40.3x, compared to 21.6x for the median of its US-listed Real Estate peers. Its price-to-sales ratio is 3.6x, close to the peer median of 3.7x, and its enterprise value to revenue ratio stands at 2.6x. The stock closed at $4.43 on October 16, 2026, representing a 56.1% decline over one year, trailing the S&P 500 return of 16.8%. Over five years, the stock dropped 66.4% compared to an 83.0% gain for the benchmark.
What analysts expect
Wall Street analyst coverage for Gyrodyne shows no published consensus price targets or formal rating counts. Over the last four quarters, the company recorded 0 earnings per share beats. The stock exhibits a beta of 0.54, reflecting lower volatility relative to the broader market, and was trading 36.4% below its 200-day moving average as of October 16, 2026.
Key risks and what to watch
- Revenue contracted 1.8% year over year in the quarter ended December 31, 2023.
- Operating cash flow remained negative across multiple periods, including -$5.5M in FY2014 and -$3,440 in FY2015.
- The firm recorded 0 earnings per share beats over the last 4 quarters.
- Trailing profit margin remains deeply negative at -137.1%.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this GYRO AI stock analysis
This page is an AI-written research summary of Gyrodyne, LLC (GYRO). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: GYRO income statement, GYRO balance sheet, GYRO key metrics, GYRO chart. See the GYRO stock overview for the latest quote and news.
GYRO AI stock analysis FAQ
What is Gyrodyne's primary business?
Gyrodyne, LLC owns, leases, and manages commercial real estate across the East Coast, with a primary strategic focus on medical office spaces.
What is Gyrodyne's valuation relative to peers?
Gyrodyne trades at a trailing P/E of 40.3x, compared to 21.6x for the median of its US-listed Real Estate peers. Its price-to-sales ratio is 3.6x, compared to the peer median of 3.7x.
Does Gyrodyne pay a dividend?
Gyrodyne currently does not report an active dividend payout.
Who owns most of Gyrodyne's stock?
Institutional investors hold 42.3% of the company's shares, while company insiders own 26.6%. Short interest represents 0.1% of the float.